The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
The immunogenetics of multiple sclerosis: A comprehensive review
Open accessAbstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and common cause of non-traumatic neurological disability in young adults. The likelihood for an individual to develop MS is strongly influenced by her or his ethnic background and family history of disease, suggesting that genetic susceptibility is a key determinant of risk. Over 100 loci have been firmly associated with susceptibility, whereas the main signal genome-wide maps to the class II region of the human leukocyte antigen (HLA) gene cluster and explains up to 10.5% of the genetic variance underlying risk. HLA-DRB1*15:01 has the strongest effect with an average odds ratio of 3.08. However, complex allelic hierarchical lineages, cis/trans haplotypic effects, and independent protective signals in the class I region of the locus have been described as well. Despite the remarkable molecular dissection of the HLA region in MS, further studies are needed to generate unifying models to account for the role of the MHC in disease pathogenesis. Driven by the discovery of combinatorial associations of Killer-cell Immunoglobulin-like Receptor (KIR) and HLA alleles with infectious, autoimmune diseases, transplantation outcome and pregnancy, multi-locus immunogenomic research is now thriving. Central to immunity and critically important for human health, KIR molecules and their HLA ligands are encoded by complex genetic systems with extraordinarily high levels of sequence and structural variation and complex expression patterns. However, studies to-date of KIR in MS have been few and limited to very low resolution genotyping. Application of modern sequencing methodologies coupled with state of the art bioinformatics and analytical approaches will permit us to fully appreciate the impact of HLA and KIR variation in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Nomenclature for factors of the HLA system, 2010
Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Fernández‐Viña, M., Geraghty, D. E., Holdsworth, R., Hurley, C. K., et al. (2010) · Tissue Antigens · doi:10.1111/j.1399-0039.2010.01466.x · Cited by 4,222
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,170
Self-citationEnvironmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
Nomenclature for Factors of the HLA System, 2004
Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Geraghty, D. E., Hansen, J. A., Hurley, C. K., Mach, B., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.02.002 · Cited by 818
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.240432 · Cited by 718
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
IMGT/HLA Database – a sequence database for the human major histocompatibility complex
Robinson, J., Malik, A., Parham, P., Bodmer, J. G., & Marsh, S. G. E. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550314.x · Cited by 694
A genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & Risch, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 615
Twin concordance and sibling recurrence rates in multiple sclerosis
Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., Ebers, G. C., & The Canadian Collaborative Study Group§§ (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932604100 · Cited by 532
A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2
Salter, R. D., Benjamin, R. J., Wesley, P. K., Buxton, S. E., Garrett, T. P. J., Clayberger, C., Krensky, A. M., Norment, A. M., Littman, D. R., & Parham, P. (1990) · Nature · doi:10.1038/345041a0 · Cited by 520
Imputation-Based Analysis of Association Studies: Candidate Regions and Quantitative Traits
Servin, B., & Stephens, M. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030114 · Cited by 515
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
Olerup, O., & Hillert, J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02029.x · Cited by 490
Promise and pitfalls of the Immunochip
Cortes, A., & Brown, M. A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3204 · Cited by 479
Parham, P., & Moffett, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3370 · Cited by 476
HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSE
Jersild, C., Hansen, G., Svejgaard, A., Fog, T., Thomsen, M., & Dupont, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90970-7 · Cited by 469
Greenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., & Sette, A. (2011) · Immunogenetics · doi:10.1007/s00251-011-0513-0 · Cited by 448
HIBAG—HLA genotype imputation with attribute bagging
Zheng, X., Shen, J., Cox, C., Wakefield, J. C., Ehm, M. G., Nelson, M. R., & Weir, B. S. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.18 · Cited by 424
Activation and function of natural killer cell responses during viral infections
Biron, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80155-0 · Cited by 420
Sawcer, S., Franklin, R. J. M., & Ban, M. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70041-9 · Cited by 401
Vader, W., Stepniak, D., Kooy, Y., Mearin, L., Thompson, A., van Rood, J. J., Spaenij, L., & Koning, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135229100 · Cited by 388
Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., & Parham, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3969 · Cited by 379
The worldwide prevalence of multiple sclerosis
Pugliatti, M., Sotgiu, S., & Rosati, G. (2002) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00036-7 · Cited by 370
The Yin and Yang of HLA and KIR in human disease
Kulkarni, S., Martin, M. P., & Carrington, M. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.06.003 · Cited by 363
Cantab, M. A. (1976) · PubMed · Cited by 356
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340
Self-citationNoble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335 · cited 6×
“DRB1*04:05 has also been found to be associated with MS in Sardinia, where the incidence of MS is quite high [65, 66], refining an early observation of an association with DR4.”
BackgroundInfluentialDifferential microRNA regulation of HLA-C expression and its association with HIV control
Kulkarni, S., Savan, R., Qi, Y., Gao, X., Yuki, Y., Bass, S. E., Martin, M. P., Hunt, P., Deeks, S. G., Telenti, A., et al. (2011) · Nature · doi:10.1038/nature09914 · Cited by 326
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., Cree, B. C. A., Begovich, A. B., Villoslada, P., Montalban, X., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl223 · Cited by 317
Self-citationPatsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., van Duijn, C. M., Noble, J. A., Raj, T., IMSGC, ANZgene, Gourraud, P.-A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003926 · Cited by 312
Self-citationMultiple Sclerosis: Association with HL—A3
NAITO, S., NAMEROW, N., MICKEY, M. R., & TERASAKI, P. I. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00111.x · Cited by 308
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
Cree, B. A. C., Khan, O., Bourdette, D., Goodin, D. S., Cohen, J. A., Marrie, R. A., Glidden, D., Weinstock-Guttman, B., Reich, D., Patterson, N., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 301
Self-citationIncidence of multiple sclerosis in multiple racial and ethnic groups
Langer-Gould, A., Brara, S. M., Beaber, B. E., & Zhang, J. L. (2013) · Neurology · doi:10.1212/wnl.0b013e3182918cc2 · Cited by 299
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Self-citationDefinition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Huang, D., Shi, F., Jung, S., Pien, G. C., Wang, J., Salazar‐Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H., Biron, C. A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5465com · Cited by 284
Haines, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 284
Surface NK receptors and their ligands on tumor cells
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., & Moretta, A. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.002 · Cited by 283
The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense
Bashirova, A. A., Martin, M. P., McVicar, D. W., & Carrington, M. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115726 · Cited by 265
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases
International MHC and Autoimmunity Genetics Network (IMAGEN)*, Rioux, J. D., Goyette, P., Vyse, T. J., Hammarström, L., Fernando, M. M. A., Green, T., De Jager, P. L., Foisy, S., Wang, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909307106 · Cited by 256
Self-citationComplex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Dyment, D. A., Herrera, B. M., Cader, M. Z., Willer, C. J., Lincoln, M. R., Sadovnick, A. D., Risch, N., & Ebers, G. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi206 · Cited by 252
Age–adjusted recurrence risks for relatives of patients with multiple sclerosis
Robertson, N. P., Fraser, M., Deans, J., Clayton, D., Walker, N., & Compston, D. A. S. (1996) · Brain · doi:10.1093/brain/119.2.449 · Cited by 234
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B
Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P., McVicar, D. W., Maenaka, K., Parham, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.33 · Cited by 228
Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
Ontaneda, D., Fox, R. J., & Chataway, J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70264-9 · Cited by 220
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service
Wallin, M. T., Culpepper, W. J., Coffman, P., Pulaski, S., Maloni, H., Mahan, C. M., Haselkorn, J. K., Kurtzke, J. F., & for the Veterans Affairs Multiple Sclerosis Centres of Excellence Epidemiology Group (2012) · Brain · doi:10.1093/brain/aws099 · Cited by 220
Hao, J., Liu, R., Piao, W., Zhou, Q., Vollmer, T. L., Campagnolo, D. I., Xiang, R., La Cava, A., Van Kaer, L., & Shi, F.-D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092749 · Cited by 213
HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review
Schmidt, H., Williamson, D., & Ashley-Koch, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk118 · Cited by 212 · cited 1×
“A HuGE (Human Genome Epidemiology) review of 72 papers published from 1993–2004 found that in all but a very few studies, the frequency of DRB1*15:01 was greater in cases than controls, and that this was by a wide margin the most consistent finding [41].”
BackgroundCommon and Well-Documented HLA Alleles
Cano, P., Klitz, W., Mack, S. J., Maiers, M., Marsh, S. G. E., Noreen, H., Reed, E. F., Senitzer, D., Setterholm, M., Smith, A., et al. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.01.014 · Cited by 212
Multi-Population Classical HLA Type Imputation
Dilthey, A., Leslie, S., Moutsianas, L., Shen, J., Cox, C., Nelson, M. R., & McVean, G. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002877 · Cited by 210
HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
Brynedal, B., Duvefelt, K., Jonasdottir, G., Roos, I. M., Åkesson, E., Palmgren, J., & Hillert, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000664 · Cited by 207
Functional epistasis on a common MHC haplotype associated with multiple sclerosis
Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., & Fugger, L. (2006) · Nature · doi:10.1038/nature05133 · Cited by 205
The Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups, Andreassen, O. A., The International Multiple Sclerosis Genetics Consortium (IMSGC), Harbo, H. F., Wang, Y., Thompson, W. K., Schork, A. J., Mattingsdal, M., Zuber, V, Bettella, F., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2013.195 · Cited by 202
Environmental risk factors for multiple sclerosis
Salzer, J. (2013) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 202
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189
Thomson, G., Valdes, A. M., Noble, J. A., Kockum, I., Grote, M. N., Najman, J., Erlich, H. A., Cucca, F., Pugliese, A., Steenkiste, A., et al. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00867.x · Cited by 189
Marrosu, M. G., Murru, R., Murru, M. R., Costa, G., Zavattari, P., Whalen, M., Cocco, E., Mancosu, C., Schirru, L., Solla, E., et al. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 180
Multiple sclerosis: Prospects and promise
Hauser, S. L., Chan, J. R., & Oksenberg, J. R. (2013) · Annals of Neurology · doi:10.1002/ana.24009 · Cited by 179
Self-citationShi, F.-D., Takeda, K., Akira, S., Sarvetnick, N., & Ljunggren, H.-G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3099 · Cited by 178
A second major histocompatibility complex susceptibility locus for multiple sclerosis
Yeo, T. W., De Jager, P. L., Gregory, S. G., Barcellos, L. F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C. J., Goodman, R. S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21063 · Cited by 175
Self-citationOkuda, D. T., Srinivasan, R., Oksenberg, J. R., Goodin, D. S., Baranzini, S. E., Beheshtian, A., Waubant, E., Zamvil, S. S., Leppert, D., Qualley, P., et al. (2009) · Brain · doi:10.1093/brain/awn301 · Cited by 174
Self-citationMultiple sclerosis: Lessons from molecular neuropathology
Lassmann, H. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.003 · Cited by 172
Harbo, H. F., Lie, B. A., Sawcer, S. J., Celius, E. G., Dai, K., Oturai, A. B., Hillert, J. A., Lorentzen, Å. R., Laaksonen, M., Myhr, K. M., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00173.x · Cited by 170
Epistasis among HLA-DRB1, HLA-DQA1,and HLA-DQB1 loci determines multiple sclerosis susceptibility
Lincoln, M. R., Ramagopalan, S. V., Chao, M. J., Herrera, B. M., DeLuca, G. C., Orton, S.-M., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812664106 · Cited by 169
Risk for myasthenia gravis maps to a 151 Pro→Ala change in TNIP1 and to human leukocyte antigen‐B*08
Gregersen, P. K., Kosoy, R., Lee, A. T., Lamb, J., Sussman, J., McKee, D., Simpfendorfer, K. R., Pirskanen‐Matell, R., Piehl, F., Pan‐Hammarstrom, Q., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23691 · Cited by 168
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
Hensiek, A. E. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.184 · Cited by 167
HLA*IMP—an integrated framework for imputing classical HLA alleles from SNP genotypes
Dilthey, A. T., Moutsianas, L., Leslie, S., & McVean, G. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr061 · Cited by 166
(2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.035 · Cited by 163
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
Tsai, S., & Santamaria, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00321 · Cited by 162
Peptide antagonism as a mechanism for NK cell activation
Fadda, L., Borhis, G., Ahmed, P., Cheent, K., Pageon, S. V., Cazaly, A., Stathopoulos, S., Middleton, D., Mulder, A., Claas, F. H. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913745107 · Cited by 158
Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Barcellos, L. F., Oksenberg, J. R., Green, A. J., Bucher, P., Rimmler, J. B., Schmidt, S., Garcia, M., Lincoln, R., Pericak‐Vance, M. A., et al. (2002) · Brain · doi:10.1093/brain/awf009 · Cited by 157
Self-citationMultiple Sclerosis and Other Demyelinating Diseases
Al-Tubaikh, J. A. (2010) · Springer eBooks · doi:10.1007/978-3-642-03709-2_13 · Cited by 156
DQ (rather than DR) gene marks susceptibility to narcolepsy
Matsuki, K., Grumet, F. C., Lin, X., Gelb, M., Guilleminault, C., Dement, W., & Mignot, E. J.-M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90571-j · Cited by 153
Multiple Sclerosis and Other Demyelinating Diseases
Bendszus, M., & Storch-Hagenlocher, B. (2013) · Medical radiology · doi:10.1007/174_2012_787 · Cited by 149
Copy Number Variation of KIR Genes Influences HIV-1 Control
Pelak, K., Need, A. C., Fellay, J., Shianna, K. V., Feng, S., Urban, T. J., Ge, D., Luca, A. D., Martínez‐Picado, J., Wolinsky, S. M., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001208 · Cited by 149
The regulatory role of natural killer cells in multiple sclerosis
Takahashi, K., Aranami, T., Endoh, M., Miyake, S., & Yamamura, T. (2004) · Brain · doi:10.1093/brain/awh219 · Cited by 149
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
Vollmer, T. L., Liu, R., Price, M. A., Rhodes, S. N., Cava, A. L., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2696 · Cited by 147
Marrosu, M. G., Murru, M. R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G., & Muntoni, F. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64074-9 · Cited by 145
The human Major Histocompatibility Complex as a paradigm in genomics research
Vandiedonck, C., & Knight, J. C. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp010 · Cited by 144
The molecular basis for HLA class II associations with rheumatoid arthritis
Nepom, G. T., Hansen, J. A., & Nepom, B. S. (1987) · Journal of Clinical Immunology · doi:10.1007/bf00915418 · Cited by 142
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis
Caillier, S. J., Briggs, F. B. S., Cree, B., Baranzini, S. E., Fernández-Viña, M., Ramsay, P. P., Khan, O. A., Royal, W., Hauser, S. L., Barcellos, L. F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5473 · Cited by 140
Self-citationAssociation between Parkinson's disease and the HLA‐DRB1 locus
Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P. H., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 139
Natural killer type 2 bias in remission of multiple sclerosis
Takahashi, K., Miyake, S., Kondo, T., Terao, K., Hatakenaka, M., Hashimoto, S., & Yamamura, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11819 · Cited by 137
The Inheritance of Resistance Alleles in Multiple Sclerosis
Ramagopalan, S. V., Morris, A. P., Dyment, D. A., Herrera, B. M., DeLuca, G. C., Lincoln, M. R., Orton, S. M., Chao, M. J., Sadovnick, A. D., & Ebers, G. C. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030150 · Cited by 135
Norman, P. J., Hollenbach, J. A., Nemat‐Gorgani, N., Guethlein, L. A., Hilton, H. G., Pando, M. J., Koram, K. A., Riley, E. M., Abi‐Rached, L., & Parham, P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003938 · Cited by 134
Self-citationJuvenile idiopathic arthritis and HLA Class I and Class II interactions and age‐at‐onset effects
Hollenbach, J. A., Thompson, S. D., Bugawan, T. L., Ryan, M. H., Sudman, M., Marion, M. C., Langefeld, C. D., Thomson, G. J., Erlich, H. A., & Glass, D. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27424 · Cited by 130
Self-citationHL‐A Antigens and Multiple Sclerosis
Bertrams, J., Kuwert, E. K., & LIEDTKE, U. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00060.x · Cited by 129
Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis
Xu, W. B., Fazekas, G., Hara, H., & Tabira, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.011 · Cited by 128
B-LYMPHOCYTE ALLOANTIGENS ASSOCIATED WITH MULTIPLE SCLEROSIS
Compston, D. A. S. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92027-4 · Cited by 128
Matsushita, T., Matsuoka, T., Isobe, N., Kawano, Y., Minohara, M., Shi, N., Nishimura, Y., Ochi, H., & Kira, J. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01172.x · Cited by 123
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
Cree, B., Reich, D., Khan, O. A., Jager, P. L. D., Nakashima, I., Takahashi, T., Bar‐Or, A., Tong, C., Hauser, S. L., & Oksenberg, J. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.541 · Cited by 117
Self-citationSardinian multiple sclerosis is associated with HLA‐DR4
Marrosu, M. G., Francesco Muntoni, A., Murru, M. R., Spinicci, G., Pischedda, M. P., Goddi, F., Cossu, P., & Pirastu, M. (1988) · Neurology · doi:10.1212/wnl.38.11.1749 · Cited by 117
Jia, P., Wang, L., Fanous, A. H., Pato, C. N., Edwards, T. L., & Zhao, Z. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002587 · Cited by 117
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
Celius, E. G., Harbo, H. F., EGELAND, T., Vartdal, F., Vandvik, B., & Spurkland, A. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00389-0 · Cited by 116
Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations
Pillai, N. E., Okada, Y., Saw, W., Ong, R. T., Wang, X., Tantoso, E., Xu, W., Peterson, T. A., Bielawny, T., Ali, M. I., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu149 · Cited by 102
Histocompatibility Determinants in Multiple Sclerosis
Jersild, C., Dupont, B., Fog, T., Platz, P., & Svejgaard, A. (1975) · Immunological Reviews · doi:10.1111/j.1600-065x.1975.tb01556.x · Cited by 101
Molecular mechanisms for contribution of MHC molecules to autoimmune diseases
Sollid, L. M., Pos, W., & Wucherpfennig, K. W. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.08.005 · Cited by 100
Interrogating the major histocompatibility complex with high-throughput genomics
de Bakker, P. I. W., & Raychaudhuri, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds384 · Cited by 100
Deschamps, R., Paturel, L., Jeannin, S., Chausson, N., Olindo, S., Béra, O., Bellance, R., Smadja, D., Césaire, D., & Cabre, P. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510382810 · Cited by 94
A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis
Field, J., Browning, S. R., Johnson, L., Danoy, P., Varney, M. D., Tait, B. D., Gandhi, K. S., Charlesworth, J., Heard, R. N., Stewart, G. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013454 · Cited by 94
B-cell alloantigen Ag 7a in multiple sclerosis
Winchester, R. J., Ebers, G. C., Fu, S. M., Espinosa, L., Zabriskie, J. B., & Kunkel, H. G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)80033-x · Cited by 92
A unified cell biological perspective on axon–myelin injury
Simons, M., Misgeld, T., & Kerschensteiner, M. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201404154 · Cited by 92
Extended major histocompatibility complex haplotypes in patients with multiple sclerosis
Hauser, S. L., Fleischnick, E., Weiner, H. L., Marcus, D., Awdeh, Z., Yunis, E. J., & Alper, C. A. (1989) · Neurology · doi:10.1212/wnl.39.2.275 · Cited by 91
Gene dose effect of theDQB1*0201allele contributes to severity of coeliac disease
Karinen, H., Kärkkäinen, P., Pihlajamäki, J., Janatuinen, E., Heikkinen, M. T., Julkunen, R. J. K., Kosma, V., Naukkarinen, A., & Laakso, M. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500206277 · Cited by 88
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients
Yoshimura, S., Isobe, N., Yonekawa, T., Matsushita, T., Masaki, K., Sato, S., Kawano, Y., Yamamoto, K., & Kira, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048592 · Cited by 87
Natural killer cells and their receptors in multiple sclerosis.
Kaur, G., Trowsdale, J., & Fugger, L. (2013) · Brain : a journal of neurology · doi:10.1093/brain/aws159 · Cited by 83
HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Kwon, O. J., Karni, A., Israel, S., Brautbar, C., Amar, A., Meiner, Z., Abramsky, O., & Karussis, D. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.555 · Cited by 82
Hamza, T. H., & Payami, H. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.13 · Cited by 80
HLA class II associated risk and protection against multiple sclerosis—a Finnish family study
Laaksonen, M., Pastinen, T., Sjöroos, M., Kuokkanen, S., Ruutiainen, J., Sumelahti, M., Reijonen, H., Salonen, R., Wikstrom, J., Panelius, M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00456-8 · Cited by 75
Genetic risk variants in African Americans with multiple sclerosis
Isobe, N., Gourraud, P., Harbo, H. F., Caillier, S. J., Santaniello, A., Khankhanian, P., Maiers, M. J., Spellman, S. R., Cereb, N., Yang, S., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfe2f · Cited by 74
Self-citationKiller cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations
Hollenbach, J. A., Nocedal, I., Ladner, M. B., Single, R. M., & Trachtenberg, E. (2012) · Immunogenetics · doi:10.1007/s00251-012-0629-x · Cited by 71
Self-citationSNP imputation in association studies
Halperin, E., & Stephan, D. A. (2009) · Nature Biotechnology · doi:10.1038/nbt0409-349 · Cited by 68
Effects of Peptide on NK Cell-Mediated MHC I Recognition
Cassidy, S., Cheent, K. S., & Khakoo, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00133 · Cited by 64
Mackie, S. L., Taylor, J., Martin, S. G., Wordsworth, P., Steer, S. E., Wilson, A. G., Worthington, J., Emery, P., Barrett, J. H., & Morgan, A. W. (2011) · Genes and Immunity · doi:10.1038/gene.2011.60 · Cited by 63
Genomewide Study of Multiple Sclerosis
Ramagopalan, S. V., Anderson, C. A., Sadovnick, A. D., & Ebers, G. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmc072836 · Cited by 61
Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis
Lorentzen, Å. R., Karlsen, T. H., Olsson, M., Smestad, C., Mero, I., Woldseth, B., Sun, J., Senitzer, D., Celius, E. G., Thorsby, E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21695 · Cited by 61
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Harbo, H. F., Isobe, N., Berg‐Hansen, P., Bos, S. D., Caillier, S. J., Gustavsen, M. W., Mero, I., Celius, E. G., Hauser, S. L., Oksenberg, J. R., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513506503 · Cited by 57
Self-citationRajapaksa, U., Li, D., Peng, Y., McMichael, A. J., Dong, T., & Xu, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204199109 · Cited by 57
Direct NK Cell-Mediated Lysis of Syngenic Dorsal Root Ganglia Neurons In Vitro
Backström, E., Chambers, B. J., Kristensson, K., & Ljunggren, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4895 · Cited by 56
The HLA locus and multiple sclerosis in Sicily
Brassat, D., Salemi, G., Barcellos, L. F., McNeill, G., Proia, P., Hauser, S. L., Oksenberg, J. R., & Savettieri, G. (2005) · Neurology · doi:10.1212/01.wnl.0000149765.71212.0a · Cited by 55
Self-citationNatural killer cell‐mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions
Backström, E., Chambers, B., Ho, E., Naidenko, O., Mariotti, R., Fremont, D., Yokoyama, W., Kristensson, K., & Ljunggren, H. (2003) · European Journal of Immunology · doi:10.1002/immu.200390012 · Cited by 54
Amirzargar, A., Mytilineos, J., Yousefipour, A., Farjadian, S., Scherer, S., Opelz, G., & Ghaderi, A. A. (1998) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.1998.00101.x · Cited by 53
Multiple Lessons for Multiple Sclerosis
Hauser, S. L. (2008) · New England Journal of Medicine · doi:10.1056/nejme0806738 · Cited by 50
Influence of KIR Diversity on Human Immunity
Parham, P. (2007) · Springer eBooks · doi:10.1007/0-387-24180-9_6 · Cited by 48
Functional Killer Ig-Like Receptors on Human Memory CD4+ T Cells Specific for Cytomegalovirus
van Bergen, J., Kooy-Winkelaar, E. M. C., van Dongen, H., van Gaalen, F. A., Thompson, A., Huizinga, T. W. J., Feltkamp, M. C. W., Toes, R. E. M., & Koning, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800455 · Cited by 46
KIRs and their HLA ligands in Remitting–Relapsing Multiple Sclerosis
Fusco, C., Guerini, F. R., Nocera, G., Ventrella, G., Caputo, D., Valentino, M. A., Agliardi, C., Gallotti, J., Morra, V. B., Florio, C., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.004 · Cited by 45
Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis
Matsuoka, T., Matsushita, T., Osoegawa, M., Kawano, Y., Minohara, M., Mihara, F., Nishimura, Y., Ohyagi, Y., & Kira, J. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508097818 · Cited by 45
Brum, D. G., Barreira, A. A., Louzada‐Júnior, P., Mendes‐Junior, C. T., & Donadi, E. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.06.009 · Cited by 42
Chao, M., Barnardo, M., Lui, G., Lincoln, M. R., Ramagopalan, S. V., Herrera, B. M., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm142 · Cited by 42
Reiche, E. M. V. (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000204 · Cited by 41
HLA‐DRβ chain residue 86 controls DRαβ dimer stability
Verreck, F. A. W., And, A. T., & Koning, F. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230624 · Cited by 40
Quelvennec, E., Béra, O., Cabre, P., Alizadeh, M., Smadja, D., Jugdé, F., Edan, G., & Sémana, G. (2003) · Tissue Antigens · doi:10.1046/j.0001-2815.2002.00008.x · Cited by 38
Modes of Action of HLA-DR Susceptibility Specificities in Multiple Sclerosis
Modin, H., Olsson, W., Hillert, J. A., & Masterman, T. (2004) · The American Journal of Human Genetics · doi:10.1086/420977 · Cited by 38
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
Cocco, E. E., Sardu, C., Pieroni, E., Valentini, M. C., Murru, R., Costa, G., Tranquilli, S., Frau, J., Coghe, G., Carboni, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033972 · Cited by 38
Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients
García‐León, J. A., Pinto-Medel, M. J., Trujillo, L. G., Gomez, C. L., Oliver‐Martos, B., Prat-Arrojo, I., Marín-Bañasco, C., Suardíaz, M., Maldonado-Sánchez, R., Fernández-Fernández, Ó., et al. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.018 · Cited by 38
A high-resolution view of NK-cell receptors: structure and function
Colonna, M., Moretta, A., Vely, F., & Vivier, É. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01697-2 · Cited by 36
Fukazawa, T., Kikuchi, S., Miyagishi, R., Miyazaki, Y., Yabe, I., Hamada, T., & Sasaki, H. (2005) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1252oa · Cited by 35
Immune regulation of multiple sclerosis
Hartung, H., Aktaş, O., Menge, T., & Kieseier, B. C. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00001-7 · Cited by 34
16th IHIW: Population Global Distribution of Killer Immunoglobulin‐like Receptor (KIR) and Ligands
Hollenbach, J. A., Augusto, D. G., Alaez, C., Bubnova, L. N., Faé, I., Fischer, G., González-Galarza, F. F., Gorodezky, C., Karabon, L., Kuśnierczyk, P., et al. (2012) · International Journal of Immunogenetics · doi:10.1111/iji.12028 · Cited by 34
Self-citationDekker, J., Eastsal, S., Jakobson, I., Gao, X., Strwart, G. J., Buhler, M. M., Hawkins, B. R., Higgins, D. A., Yu, Y. L., & Serjeantson, S. W. (1993) · Tissue Antigens · doi:10.1111/j.1399-0039.1993.tb01974.x · Cited by 27
Evaluation of HLA‐DRB1 imputation using a Finnish dataset
Vlachopoulou, E., Lahtela, E., Wennerström, A., Havulinna, A. S., Salo, P. P., Perola, M., Salomaa, V. V., Nieminen, M. S., Sinisalo, J. P., & Lokki, M. (2014) · Tissue Antigens · doi:10.1111/tan.12343 · Cited by 23
The role of KIR2DS1 in multiple sclerosis - KIR in Portuguese MS patients
Bettencourt, A., SILVA, A. C. F. D., Carvalho, C., Leal, B., Santos, E., Costa, P., & da Silva, B. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.01.009 · Cited by 22
HLA dosage effect in narcolepsy with cataplexy
van der Heide, A., Verduijn, W., Haasnoot, G. W., Drabbels, J. J. M., Lammers, G. J., & Claas, F. H. J. (2014) · Immunogenetics · doi:10.1007/s00251-014-0808-z · Cited by 22
A new HLA‐B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5
Dubois, V., Tiercy, J. ‐., Labonne, M. P., Dormoy, A., & Gebuhrer, L. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00134.x · Cited by 22
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis
Jelčić, I., Hsu, K. C., Kakalacheva, K., Breiden, P., Dupont, B., Uhrberg, M., Martinꝉ, R., Münz, C., & Lünemann, J. D. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431726 · Cited by 19
Hoarau, J., Césari, M., Caillens, H., Cadet, F., & Pabion, M. (2003) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00140.x · Cited by 18
Karni, A., Kohn, Y., Saftirmnn, C., Abraimsky, O., Barcellos, L. F., Oksenberg, J. R., Kahana, E., Karussis, D., Chapman, J., & Brautbur, C. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500i607 · Cited by 17
Self-citationPreliminary analysis of a KIR haplotype estimation algorithm: a simulation study
Gourraud, P., Gagne, K., Bignon, J. D., Cambon‐Thomsen, A., & Middleton, D. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.762_4.x · Cited by 16
Hsieh, A., Chang, S., Chen, P., Chu, C., Hsiao, C., Yang, W., Chang, C.-C., Wu, J., Chen, Y.-T., Chang, T., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-81 · Cited by 13
Marrosu, M. G., Cocco, E. E., Costa, G., Murru, M. R., Mancosu, C., Murru, R., Lai, M. L., Sardu, C., & Contu, P. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0957-y · Cited by 13
Karni, A., Kohn, Y., Safirman, C., Abramsky, O., Barcellos, L., Oksenberg, J. R., Kahana, E., Karussis, D., Chapman, J., & Brautbar, C. (1999) · Multiple Sclerosis Journal · doi:10.1191/135245899678846438 · Cited by 12
Self-citation[Association of Parkinson's disease with HLA-B17 and B18 antigens].
Emile, J., Jl, T., POUPLARD, A., & Hurez, D. (1977) · PubMed · Cited by 8
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Dobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Moser, T., Akgün, K., Proschmann, U., Sellner, J., & Ziemssen, T. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102647 · Cited by 302
Mitochondrial Dysfunction and Multiple Sclerosis
Barcelos, I. P. D., Troxell, R. M., & Graves, J. S. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 291
Metadata
- Authors
- Hollenbach, J. A., & Oksenberg, J. R.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 64
- Pages
- 13-25
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W775956452
- Cited by
- 420
- References
- 162
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.